Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06327035
Recruiting Observational

Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center

NCT06327035 · tracked via the Priya Life Science France tracker
Sponsor
Clinique Les Trois Soleils
Phase
Observational
Started
2024-03-26
Last updated
2026-03-17

Condition(s) studied

StrokeGait, Hemiplegic

Investigational drug(s) / intervention(s)

Gait rehabilitation

Gait rehabilitation: Assessment of gait and balance abilities after stroke during neurorehabilitation from the subacute phase of stroke to 6 months after stroke. The assessments will be carried out on entrance to the neurological center, then at 1 ,3 and 6 months and on hospital discharge.

Study summary

The goal of this observational study is to describe the evolution of gait recovery during the subacute phase of stroke up to six months after stroke, in patients hospitalized in medical and neurological rehabilitation units.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient hospitalized in one of the investigating centers after acute/subacute stroke. * Affiliated to a social security scheme Exclusion Criteria: * Opposed to its participation in this study * Neurodegenerative disease impacting gait prior to stroke onset * Patient not walking before stroke * Progressive pathology with life-threatening consequences within 6 months * Patient under legal protection

Primary outcome measure(s)

  • Functional Ambulation Classification — Functional Ambulation Classification will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).
    The Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability.

Trial sites (3)

FacilityCityRegionStatus
Le Normandy Granville Normandy Recruiting
Clinique Les Trois Soleils Boissise-le-Roi France Recruiting
La Clinique Les Trois Soleils Boissise-le-Roi France Recruiting

More Clinique Les Trois Soleils trials in France

Effects of Optokinetic Stimulation Without a Reading Task in Patients With Hemianopic Alexia Starting soon
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2) Recruiting

Other trials for the same condition

Fine Motor Skills and Post-Stroke Swallowing Active, not recruiting
Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia Starting soon
Effects of HIIT on HRV in Sub-acute Post-stroke Patients Active, not recruiting
Effects of Optokinetic Stimulation Without a Reading Task in Patients With Hemianopic Alexia Starting soon
Neuroplasticity After Proprioceptive Rehabiliation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06327035 on ClinicalTrials.gov ↗ ← All trials in France